Qiagen N.V. (ETR:QIA)
37.02
-0.59 (-1.57%)
Apr 25, 2025, 5:35 PM CET
Qiagen Revenue
In the year 2024, Qiagen had annual revenue of $1.98B USD with 0.66% growth. Qiagen had revenue of $521.20M in the quarter ending December 31, 2024, with 2.36% growth.
Revenue
$1.98B
Revenue Growth
+0.66%
P/S Ratio
4.29
Revenue / Employee
$366.61K
Employees
5,396
Market Cap
8.20B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.98B | 12.90M | 0.66% |
Dec 31, 2023 | 1.97B | -176.21M | -8.23% |
Dec 31, 2022 | 2.14B | -110.14M | -4.89% |
Dec 31, 2021 | 2.25B | 381.31M | 20.39% |
Dec 31, 2020 | 1.87B | 343.92M | 22.53% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Qiagen News
- 3 days ago - QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025 - Wallstreet:Online
- 3 days ago - QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025 - Business Wire
- 10 days ago - Activist investor Fivespan takes stake in Qiagen - Bloomberg - Seeking Alpha
- 10 days ago - Qiagen NV (QGEN) Announces Launch of New Sample Preparation Instruments | QGEN stock news - GuruFocus
- 10 days ago - QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation - Wallstreet:Online
- 10 days ago - QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation - Business Wire
- 17 days ago - QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast - Wallstreet:Online
- 17 days ago - QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast - Business Wire